ATC code A08
(Redirected from ATC code A08AB)
| ATC code A: Alimentary tract and metabolism |
|---|
|
| Other ATC codes |
ATC code A08 Antiobesity preparations, excluding diet products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A08 is part of the anatomical group A Alimentary tract and metabolism.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA08.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
- A08AA01 Phentermine
- A08AA02 Fenfluramine
- A08AA03 Amfepramone
- A08AA04 Dexfenfluramine
- A08AA05 Mazindol
- A08AA06 Etilamfetamine
- A08AA07 Cathine
- A08AA08 Clobenzorex
- A08AA09 Mefenorex
- A08AA10 Sibutramine
- A08AA11 Lorcaserin
- A08AA12 Setmelanotide
- A08AA51 Phentermine and topiramate
- A08AA56 Ephedrine, combinations
- A08AA62 Bupropion and naltrexone
A08AB Peripherally acting antiobesity products
[edit]- A08AB01 Orlistat
- QA08AB90 Mitratapide
- QA08AB91 Dirlotapide
A08AX Other antiobesity drugs
[edit]- A08AX01 Rimonabant
See also
[edit]- Diet products are in the ATC group V06A.
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code A08". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QA08". WHO Collaborating Centre for Drug Statistics Methodology.